Cardiovascular Diseases
Cardiovascular·MeSH: Cardiovascular Diseases
Prevalence
8121.9 / 100K
Incidence
682.0 / 100K/yr
5 drugs in development·4 companies·46 clinical trials
Drug Pipeline by Phase
Phase 3(3)
Phase 2(1)
| Drug | Company |
|---|---|
| sln360 | Silence Therapeutics Plc (SLN) |
Phase 1/Phase 2(1)
| Drug | Company |
|---|---|
| tb-500 | IO Biotech, Inc. (IOBT) |
Compare drugs
Frequently asked questions
How many drugs are in development for Cardiovascular Diseases?
BioSniper tracks 5 drugs in development for Cardiovascular Diseases across 4 companies.
How many clinical trials target Cardiovascular Diseases?
There are 46 clinical trials targeting Cardiovascular Diseases tracked by BioSniper.
What is the prevalence of Cardiovascular Diseases?
The estimated prevalence of Cardiovascular Diseases is approximately 8121.9 per 100,000 population.
Deep-dive into Cardiovascular Diseases
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis